0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

biosciences/Malar J


53 results

Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker.Abade, N. A. Mgawe, C. Ndwiga, L. Kimenyi, K. M. Ochola-Oyier, L. I.
Malar J, (2025). 24:452

A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): toward a National Surveillance Framework and Data Repository.Wamae, K. Magudha, J. Asiimwe, E. Kimani, K. Kandie, R. Keitany, K. Snow, R. W. Ochola-Oyier, L. I.
Malar J, (2025). 24:413

MALDI-TOF MS for identification of Afro-tropical secondary malaria vectors.Tuwei, M. Karisa, J. Wanjiku, C. Kiuru, C. Ondieki, Z. Odongo, T. Mure, F. Otieno, B. Meli, P. Okoko, M. Bartilol, B. Gona, R. Constantino, L. Cole, G. Anastacio, T. Armazia, R. Alves, C. Rui, P. Ramaita, E. Rono, M. Candrinho, B. Mwangangi, J. Mbogo, C. Charlwood, D. Saute, F. Rabinovich, R. Chaccour, C. Maia, M. F.
Malar J, (2025). 24:284

Phenotypic and genotypic insecticide resistance profiles of main malaria vectors in Kwale county, coastal Kenya.Okoko, M. Karisa, J. Gona, R. Odongo, T. Otieno, B. Yaa, F. Bartilol, B. Meli, P. Ondieki, Z. Tuwei, M. Wanjiku, C. Shee, F. Chaccour, C. Kiuru, C. Maia, M. F.
Malar J, (2025). 24:191

Stable Plasmodium falciparum merozoite surface protein-1 allelic diversity despite decreasing parasitaemia in children with multiple malaria infections.Yaa, R. M. Kimenyi, K. M. Palasciano, H. A. Obiero, G. Ochola-Oyier, L. I.
Malar J, (2025). 24:136

Multiple insecticide resistance in Anopheles funestus from Mopeia, Central Mozambique.Kiuru, C. Constantino, L. Cole, G. Karisa, J. Wanjiku, C. Okoko, M. Candrinho, B. Saute, F. Rabinovich, N. R. Chaccour, C. Maia, M. F.
Malar J, (2025). 24:81

Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya.Onyango, T. Nuru, K. Kazungu, K. Wangari, W. Chaccour, C. Regina Rabinovich, N. Mwangangi, J. Maia, M. Jones, C.
Malar J, (2025). 24:79

The Anopheles coluzzii range extends into Kenya: detection, insecticide resistance profiles and population genetic structure in relation to conspecific populations in West and Central Africa.Kamau, L. Bennett, K. L. Ochomo, E. Herren, J. Agumba, S. Otieno, S. Omoke, D. Matoke-Muhia, D. Mburu, D. Mwangangi, J. Ramaita, E. Juma, E. O. Mbogo, C. Barasa, S. Miles, A.
Malar J, (2024). 23:122

A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors.Ominde, K. M. Kamau, Y. Karisa, J. Muturi, M. N. Kiuru, C. Wanjiku, C. Babu, L. Yaah, F. Tuwei, M. Musani, H. Ondieki, Z. Muriu, S. Mwangangi, J. Chaccour, C. Maia, M. F.
Malar J, (2023). 22:291

Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.Mwai, K. Nkumama, I. Thairu, A. Mburu, J. Odera, D. Kimathi, R. Nyamako, L. Tuju, J. Kinyanjui, S. Musenge, E. Osier, F.
Malar J, (2022). 21:326

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018.Kimenyi, K. M. Wamae, K. Ngoi, J. M. de Laurent, Z. R. Ndwiga, L. Osoti, V. Obiero, G. Abdi, A. I. Bejon, P. Ochola-Oyier, L. I.
Malar J, (2022). 21:192

Factors influencing health workers' compliance with outpatient malaria 'test and treat' guidelines during the plateauing performance phase in Kenya, 2014-2016.Amboko, B. Stepniewska, K. Machini, B. Bejon, P. Snow, R. W. Zurovac, D.
Malar J, (2022). 21:68

Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial.Mzumara, G. Leopold, S. Marsh, K. Dondorp, A. Ohuma, E. O. Mukaka, M.
Malar J, (2021). 20:282

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations.Ndwiga, L. Osoti, V. Ochwedo, K. O. Wamae, K. Bejon, P. Rayner, J. C. Githinji, G. Ochola-Oyier, L. I.
Malar J, (2021). 20:278

Determinants of the varied profiles of Plasmodium falciparum infections among infants living in Kintampo, Ghana.Botwe, A. K. Oppong, F. B. Gyaase, S. Owusu-Agyei, S. Asghar, M. Asante, K. P. Farnert, A. Osier, F.
Malar J, (2021). 20:240

Spatial-temporal clustering of malaria using routinely collected health facility data on the Kenyan Coast.Kamau, A. Mtanje, G. Mataza, C. Bejon, P. Snow, R. W.
Malar J, (2021). 20:227

Building momentum for malaria vaccine research and development: key considerations.Chitnis, C. E. Schellenberg, D. Vekemans, J. Asturias, E. J. Bejon, P. Collins, K. A. Crabb, B. S. Herrera, S. Laufer, M. Rabinovich, N. R. Roestenberg, M. Shearley, A. Tinto, H. Wentworth, M. O'Brien, K. Alonso, P.
Malar J, (2020). 19:421

Trends in health workers' compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010-2016.Amboko, B. Stepniewska, K. Macharia, P. M. Machini, B. Bejon, P. Snow, R. W. Zurovac, D.
Malar J, (2020). 19:406

Evaluating the impact of larviciding with Bti and community education and mobilization as supplementary integrated vector management interventions for malaria control in Kenya and Ethiopia.Mutero, C. M. Okoyo, C. Girma, M. Mwangangi, J. Kibe, L. Ng'ang'a, P. Kussa, D. Diiro, G. Affognon, H. Mbogo, C. M.
Malar J, (2020). 19:390

Malaria infection, disease and mortality among children and adults on the coast of Kenya.Kamau, A. Mtanje, G. Mataza, C. Mwambingu, G. Mturi, N. Mohammed, S. Ong'ayo, G. Nyutu, G. Nyaguara, A. Bejon, P. Snow, R. W.
Malar J, (2020). 19:210